ABVC BioPharma, Inc.
General ticker "ABVC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $118.1M (TTM average)
ABVC BioPharma, Inc. does not follow the US Stock Market performance with the rate: -22.0%.
Estimated limits based on current volatility of 4.1%: low 0.82$, high 0.89$
Factors to consider:
- Total employees count: 19 (0.0%) as of 2025
- Top business risk factors: Insufficient capital, Clinical trial failure, Regulatory and compliance, Market competition, Product liability
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.28$, 1.14$]
- 2025-12-31 to 2026-12-31 estimated range: [0.33$, 1.27$]
Financial Metrics affecting the ABVC estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -27.92 <= 0.28
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 0 > -0.64
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 16.26 <= 18.97
Short-term ABVC quotes
Long-term ABVC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.97MM | $0.15MM | $0.51MM |
| Operating Expenses | $16.08MM | $6.92MM | $5.21MM |
| Operating Income | $-15.11MM | $-6.77MM | $-4.71MM |
| Non-Operating Income | $-0.40MM | $-1.26MM | $-0.66MM |
| Interest Expense | $0.29MM | $1.31MM | $0.83MM |
| R&D Expense | $2.69MM | $1.06MM | $0.18MM |
| Income(Loss) | $-15.51MM | $-8.02MM | $-5.37MM |
| Taxes | $0.80MM | $0.26MM | $-0.11MM |
| Net Income(Loss)* | $-16.42MM | $-7.79MM | $-4.90MM |
| Stockholders Equity | $3.10MM | $1.55MM | $1.23MM |
| Assets | $9.58MM | $7.78MM | $7.54MM |
| Operating Cash Flow | $-7.40MM | $-4.24MM | $-1.81MM |
| Capital expenditure | $0.12MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $-1.72MM | $-0.36MM | $0.00MM |
| Financing Cash Flow | $4.01MM | $3.92MM | $1.98MM |
| Earnings Per Share** | $-5.19 | $-1.80 | $-0.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.